Relationships Between a Range of Inflammatory Biomarkers and Subjective Sleep Quality in Chronic Insomnia Patients: A Clinical Study
Lan Xia,Ping Zhang,Jing-Wen Niu,Wei Ge,Jun-Tao Chen,Shuai Yang,Ai-Xi Su,Yi-Zhou Feng,Fang Wang,Gong Chen,Gui-Hai Chen
DOI: https://doi.org/10.2147/NSS.S310698
2021-08-12
Nature and Science of Sleep
Abstract:Lan Xia, 1, &ast Ping Zhang, 2, &ast Jing-Wen Niu, 2 Wei Ge, 2 Jun-Tao Chen, 2 Shuai Yang, 2 Ai-Xi Su, 2 Yi-Zhou Feng, 2 Fang Wang, 3 Gong Chen, 4 Gui-Hai Chen 2 1 Department of Neurology, The Second Affiliated Hospital of Anhui Medical University, Hefei, People's Republic of China; 2 Department of Neurology (Sleep Disorders), The Affiliated Chaohu Hospital of Anhui Medical University, Hefei (Chaohu), People's Republic of China; 3 Department of Neurology, The First Affiliated Hospital of Anhui Medical University, Hefei, People's Republic of China; 4 Hefei Technology College, Hefei (Chaohu), People's Republic of China &astThese authors contributed equally to this work Correspondence: Gui-Hai Chen Department of Neurology (Sleep Disorders), The Affiliated Chaohu Hospital of Anhui Medical University, Hefei (Chaohu), People's Republic of China Tel/Fax +86-551-82321571 Email 163.com Gong Chen Hefei Technology College, Hefei (Chaohu), People's Republic of China Tel +86-551-82367072 Fax +86-551-82351650 Email Purpose: To examine whether associations exist between chronic insomnia disorder (CID) and overlooked inflammatory factors (Serum amyloid protein A [SAA]), tumor necrosis factor [TNF]-α, granulocyte-macrophage colony-stimulating factor [GM-CSF], and regulated on activation and normal T cell expressed and presumably secreted [RANTES]). Patients and Methods: A total of 65 CID patients and 39 sex- and age-matched good sleeper (GS) controls participated in this study. They completed a baseline survey to collect data on demographics, and were elevated sleep and mood by Pittsburgh Sleep Quality Index (PSQI), Athens Insomnia Scale (AIS), 17-item Hamilton Depression Rating Scale (HAMD-17) and 14-item Hamilton Anxiety Rating Scale (HAMA-14), respectively. The blood samples were collected and tested the serum levels of SAA, TNF-α, GM-CSF and RANTES. Results: The CID group had higher serum levels of SAA, TNF-α, and GM-CSF and a lower level of RANTES than the GS group. In the Spearman correlation analysis, SAA and GM-CSF positively correlated with the PSQI and AIS scores. After controlling for sex, HAMD-17 score, and HAMA-14 score, the partial correlation analysis showed that GM-CSF was positively correlated with PSQI score. Further stepwise linear regression analyses showed that GM-CSF was positively associated with the PSQI and AIS scores, while RANTES was negatively associated with them, and SAA was positively associated with just the AIS score. Conclusion: The serum levels of inflammatory mediators (SAA, TNF-α, and GM-CSF) were significantly elevated and the level of RANTES was significantly decreased in CID patients and, to some extent, the changes are related to the severity of insomnia. These findings may help us to improve interventions to prevent the biological consequences of CID by inhibiting inflammation, thereby promoting health. Keywords: chronic insomnia disorder, serum amyloid protein A; tumor necrosis factor (TNF)-α, granulocyte-macrophage colony-stimulating factor, regulated on activation and normal T cell expressed and presumably secreted In the general population, about a third of individuals have sleep complaints, and nearly 10% fulfill the diagnostic criteria for chronic insomnia disorder (CID). 1 CID has a strong impact on quality of life and is a risk factor for the development of other disorders, including psychological disease, 2 , 3 cardiovascular disease, 4 diabetes, 5 certain cancers, 6 obesity, 7 and functional decline. This has substantial public health implications. In recent years, sleep research has increasingly focused on the biological mechanisms underlying these associations between insomnia and somatic diseases, 8–10 with substantial attention on the effect of chronic sleep loss on inflammation. Compelling evidence has demonstrated that sleep disturbance (defined as difficulty initiating or maintaining sleep) and shorter sleep duration are associated with elevated inflammatory biomarkers, which may be linked to increased risk of chronic diseases. 11–13 A systematic review and meta-analysis of 72 studies (n > 50,000) examined associations between insomnia and the proinflammatory markers interleukin (IL)-6 and the acute-phase protein C-reactive protein (CRP).< -Abstract Truncated-
neurosciences,clinical neurology